Micron Beats, Semaglutide Combo, Gemini Doubts (+5 more stories)

The Daily Business and Finance Show - Thursday, 1 October 2026

We get our business and finance news from Seeking Alpha and you should too! Subscribe to Seeking Alpha Premium for more in-depth market news and help support this podcast. Free for 14-days! Please click here for more info: Subscribe to Seeking Alpha Premium News Today's headlines: Micron rises as Q4 results, guidance top estimates Regeneron drug said to cut muscle loss when combined with Novo's semaglutide Google reportedly faces internal doubts over Gemini 4 performance 3 things to look out for on Thursday House Democrats seek investigation into taxpayer-funded Trump ads AM Need to Know: Micron beats estimates, Amazon expands nuclear deal & more Stock futures mixed as October begins, Micron reports strong earnings China's Tencent taps Oracle for 100,000 AI chips in $7B lease deal - report Explanations from OpenAI ChatGPT API with proprietary prompts. This podcast provides information only and should not be construed as financial or business advice. This podcast is produced by Klassic Studios Learn more about your ad choices. Visit megaphone.fm/adchoices